InMode Ltd. has announced a significant legal victory in its ongoing efforts to protect patients and medical providers from counterfeit aesthetic devices. A U.S. court has issued a permanent injunction prohibiting the unauthorized sale and distribution of fake Morpheus8 radio frequency (RF) microneedling devices and needle cartridges. The ruling marks a major milestone in InMode’s intellectual property enforcement campaign and underscores the company's commitment to maintaining the safety, effectiveness, and integrity of its FDA-cleared technologies.
The Morpheus8 system is a clinically proven device used by licensed medical professionals to deliver minimally invasive RF microneedling treatments for skin remodeling, tightening, and rejuvenation. Counterfeit versions of the Morpheus8 and its accessories not only violate InMode's patents and trademarks, but also jeopardize patient safety due to inferior materials, poor manufacturing standards, and lack of regulatory approval. InMode has cautioned that using unauthorized equipment can lead to inconsistent results and serious complications.
InMode reiterated its commitment to aggressively pursuing legal action against entities involved in producing or distributing counterfeit products. The company encourages providers to purchase equipment and consumables only through authorized channels to ensure they receive genuine, high-quality devices. With this injunction, InMode reinforces its role as a leader in safe and innovative aesthetic technologies, while protecting the trust of medical professionals and patients alike.
MedTech Spectrum's Summary